Santen Pharmaceutical (OTCMKTS:SNPHY) Shares Gap Down – Here’s What Happened

Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY)’s share price gapped down prior to trading on Friday . The stock had previously closed at $13.89, but opened at $13.19. Santen Pharmaceutical shares last traded at $13.19, with a volume of 180 shares changing hands.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Santen Pharmaceutical to a “hold” rating in a report on Monday, April 13th. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company has an average rating of “Hold”.

Santen Pharmaceutical Price Performance

The stock has a market capitalization of $4.25 billion and a P/E ratio of 0.10. The stock has a fifty day moving average price of $12.06 and a 200 day moving average price of $11.35.

Santen Pharmaceutical Company Profile

Santen Pharmaceutical Co, Ltd. is a Japan?based specialty pharmaceutical company focused exclusively on ophthalmology. Headquartered in Osaka, Santen engages in the research, development, manufacture and marketing of prescription and over?the?counter products for the diagnosis and treatment of eye diseases. Its core product portfolio includes therapies for glaucoma, dry eye, retinal disorders, uveitis and post?operative care, as well as surgical equipment and diagnostic agents designed to support comprehensive eye care.

With roots tracing back to the late 19th century, Santen has grown from a domestic manufacturer to a global ophthalmic specialist.